(Date:10/10/2008)... of disease by 20 years after operation, study say...- Liver transplant patients have a higher incidenc...rchers in Finland. , In a new study published ...esearchers investigated the cancer risk pattern in...inki University Central Hospital. The patients wer...
(Date:10/10/2008)...wswire/ -- More than 600 new Wisconsin,voters can ... This is the,result of Aurora Health Care,s voter ...ll of the health care system,s 13 hospitals across...p to vote at the drives., Aurora employees and vo...ment Accountability Board to serve as special regi...
(Date:10/10/2008)... completion of a highly successful CIO Finance Sum...nounces their next business technology gathering, ...cutives in healthcare. CDM Media has confirmed the... at the Four Seasons Resort in Scottsdale, AZ. , ...er 11, 2008 -- Upon the completion of a highly suc...
(Date:10/10/2008)...ct. 10 /PRNewswire/ -- A senior citizen,soared ove...in a small,plane. The high-flying adventure was ta...ill came from a last-wish program through Silverad...ng, where Heden was a patient.,Called Go Wish, the...lped,many realize a special activity at the end of...
Breaking Medicine News(10 mins):Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2...liam Styron, 81, the famous Pulitzer Prize-winning...in Massachusetts.// According to his daughter, Ale...Hospital. He belonged to Virginia. He was obsessi...hat made him write novels like "Lie Down In Darkne...
...Shun, 55, from China is the world’s tallest man al...s Day is to be celebrated across the globe on Nove... in the celebrations. His record will be publishe... which he will autograph in Rio de Janeiro. He wil...
...ording to a government data, the number of deaths ...years//. The Office for National Statistics (ONS)... was 4,144 in the year 1991 and it has risen to 8,...the experts, the lower price and easy accessibilit...
... eyes could reveal the status of our health and he... disease.// Conventional vision tests reveal eyesi...ut according to professor Emanuel Rosen, of Rosen ... a test of retina can identify early signs of cond...
Other Medicine News:Health News:Deaths due to heavy drinking has doubled in 15 years 2Health News:Eye could reveal serious health disorder 2(Date:10/7/2008)...Study Showed Larazotide Acetate Prevented Immunolo...atients with Celiac Disease, Additional Data Indic...ase, ORLANDO, Fla., Oct. 7 /- Alba T... clinical studies this week at the American,Colleg... Meeting. Data from,study CLIN 1001-004, the first...
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A st...mining embryonic stem cell self-renewal,reported ...tim (recombinant,human serum albumin) was an effec...l culture., The article entitled, "The ground sta... that researchers used Cellastim as a recombinant,...
(Date:10/7/2008)... BERKELEY, Calif., Oct. 7 /- Aerovan...fety data from a Phase I trial of its Aerovant,inh...with no evidence of,local irritancy following asth...This 10 mg dose will be the highest of three doses...g study, which is scheduled to begin early,next ye...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Arde...ay that a poster entitled "RDEA119, a Potent,and H...Dextran Sulfate,Sodium (DSS) -- induced Chronic Co...ege of Gastroenterology (ACG) 2008 Annual Meeting ...ta from a preclinical study of,RDEA119, the Compan...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4NeoGenomics to Present at the Noble Financial Equity Conference 25367 1NeoGenomics to Present at the Noble Financial Equity Conference 25367 2Courage Center Seeks Applications for Judd Jacobson Memorial Award 25364 1Courage Center Seeks Applications for Judd Jacobson Memorial Award 25364 2REMOXY 28R 29 NDA Filing Accepted by FDA and Priority Review Granted 2827 1REMOXY 28R 29 NDA Filing Accepted by FDA and Priority Review Granted 2827 2REMOXY 28R 29 NDA Filing Accepted by FDA and Priority Review Granted 2827 3New Test Scans Beef for Mad Cow Disease 25361 1New Test Scans Beef for Mad Cow Disease 25361 2...ESS WIRE)--Jun 21, 2007 - Opexa,Therapeutics, Inc....ent and commercialization of cell therapies, today... Phase I/II,extension clinical trial of the invest...e sclerosis (MS). In this one-year,8-subject exte...,and secondary progressive (SPMS) subjects, Tovaxi...
...ne 21, 2007 - “In anaplastic,astrocytoma, AP...or,to temozolomide,” Prof. Albert Wong, M.D....d on the international Phase,IIb study with the TG...Antisense Pharma. Prof. Wong discussed the results...central nervous system tumors,at the 43rd Annual M...
Other Medicine Technology:Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 2Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 5Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4This single lamp light source is perfect for surgeon's offices, cath labs, dermatology offices, and specialty uses.
The 300W effective dual light source has quality xenon performance.
Cold light source single outlet.
Cold light source triple outlet.
Medicine Products: